W STRATEGIES, LLC for BIOGEN
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
FY 2019 Labor/HHS appropriations bills as it relates to funding for newborn screening. Education about the RUSP (Recommended Uniform Screening Panel) as it relates to SMA. Education about innovative contracting and value based payments. Education about Alzheimer's Disease and implications for the health care system. Trump Administration Rx Pricing Blueprint.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Medicare/Medicaid MMM
Education about obstacles to patient access for coverage of rare disease therapies in Medicaid. H.R.1892: Bipartisan Budget Act of 2018 as it relates to a Part D "donut hole" provision.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.